Toxicologic Pathology,
Journal Year:
2019,
Volume and Issue:
48(2), P. 277 - 294
Published: Oct. 23, 2019
Toxicologic
pathology
is
transitioning
from
analog
to
digital
methods.
This
transition
seems
inevitable
due
a
host
of
ongoing
social
and
medical
technological
forces.
Of
these,
artificial
intelligence
(AI)
in
particular
machine
learning
(ML)
are
globally
disruptive,
rapidly
growing
sectors
technology
whose
impact
on
the
long-established
field
histopathology
quickly
being
realized.
The
development
increasing
numbers
algorithms,
peering
ever
deeper
into
histopathological
space,
has
demonstrated
scientific
community
that
AI
platforms
now
poised
truly
future
precision
personalized
medicine.
However,
as
with
all
great
advances,
there
implementation
adoption
challenges.
review
aims
define
common
relevant
ML
terminology,
describe
data
generation
interpretation,
outline
current
potential
business
cases,
discuss
validation
regulatory
hurdles,
most
importantly,
propose
how
overcoming
challenges
this
burgeoning
may
shape
toxicologic
for
years
come,
enabling
pathologists
contribute
even
more
effectively
answering
questions
solving
global
health
issues.
[Box:
see
text]
Anesthesiology,
Journal Year:
2019,
Volume and Issue:
132(2), P. 379 - 394
Published: Sept. 15, 2019
Abstract
Artificial
intelligence
has
been
advancing
in
fields
including
anesthesiology.
This
scoping
review
of
the
intersection
artificial
and
anesthesia
research
identified
summarized
six
themes
applications
anesthesiology:
(1)
depth
monitoring,
(2)
control
anesthesia,
(3)
event
risk
prediction,
(4)
ultrasound
guidance,
(5)
pain
management,
(6)
operating
room
logistics.
Based
on
papers
review,
several
topics
within
were
described
summarized:
machine
learning
(including
supervised,
unsupervised,
reinforcement
learning),
techniques
(e.g.,
classical
learning,
neural
networks
deep
Bayesian
methods),
major
applied
intelligence.
The
implications
for
practicing
anesthesiologist
are
discussed
as
its
limitations
role
clinicians
further
developing
use
clinical
care.
potential
to
impact
practice
anesthesiology
aspects
ranging
from
perioperative
support
critical
care
delivery
outpatient
management.
Computational and Structural Biotechnology Journal,
Journal Year:
2020,
Volume and Issue:
18, P. 2300 - 2311
Published: Jan. 1, 2020
Artificial
intelligence
(AI)
and
machine
learning
have
significantly
influenced
many
facets
of
the
healthcare
sector.
Advancement
in
technology
has
paved
way
for
analysis
big
datasets
a
cost-
time-effective
manner.
Clinical
oncology
research
are
reaping
benefits
AI.
The
burden
cancer
is
global
phenomenon.
Efforts
to
reduce
mortality
rates
requires
early
diagnosis
effective
therapeutic
interventions.
However,
metastatic
recurrent
cancers
evolve
acquire
drug
resistance.
It
imperative
detect
novel
biomarkers
that
induce
resistance
identify
targets
enhance
treatment
regimes.
introduction
next
generation
sequencing
(NGS)
platforms
address
these
demands,
revolutionised
future
precision
oncology.
NGS
offers
several
clinical
applications
important
risk
predictor,
detection
disease,
by
medical
imaging,
accurate
prognosis,
biomarker
identification
discovery.
generates
large
demand
specialised
bioinformatics
resources
analyse
data
relevant
clinically
significant.
Through
AI,
diagnostics
prognostic
prediction
enhanced
with
imaging
delivers
high
resolution
images.
Regardless
improvements
technology,
AI
some
challenges
limitations,
application
remains
be
validated.
By
continuing
progression
innovation
show
great
promise.
The Lancet,
Journal Year:
2021,
Volume and Issue:
398(10315), P. 1997 - 2050
Published: Oct. 7, 2021
At
the
end
of
2019,
first
reports
a
new
respiratory
virus
appeared
in
China.
The
subsequent
COVID-19
pandemic
has
affected
every
person,
country,
world.
One
early
lesson
was
crucial
importance
timely
accurate
diagnosis.
A
second
widespread
scarcity
such
diagnostic
capacity
and
capability.
supported
findings
2018
Lancet
Series
on
Pathology
Laboratory
Medicine
Low-Income
Middle-Income
Countries,
namely
that
despite
diagnostics
being
central
to
health
care,
access
testing
pathology
laboratory
medicine
(PALM)
is
poor
inequitable
many
parts
In
imaging
(DI),
other
major
discipline,
data
are
scarce,
but
what
available
suggest
situation
similar
or
even
worse.
Poor
accessibility
not
issue.
2008,
Maputo
Declaration
Strengthening
Systems
identified
need
address
problems
testing.
Although
progress
been
slow,
there
now
conjunction
factors
potential
accelerate
change.
First,
three
global
priorities—universal
coverage,
antimicrobial
resistance,
security—all
require
better
diagnostics.
Second,
publication
an
essential
list
(EDL)
for
priority
settings
by
WHO
key
step
recognising
Third,
greatly
raised
awareness
Lastly,
within
past
15
years,
extraordinary
innovations
technology
informatics
promise
transformation
across
all
aspects
combination
these
can
fuel
political
will
This
Commission
Diagnostics
set
up
with
remit
analysing
issues
identifying
solutions
both
PALM
DI,
part
because
two
disciplines
because,
increasingly,
optimum
patient
care
(eg,
cancer)
depends
integration
synthesis
results
disciplines.
Also,
share
same
issues;
example,
insufficient
financial
support,
staff
shortages,
infrastructure
problems,
low
visibility
and,
hence,
priority.
this
Commission,
we
analyse
current
status
use
six
building
blocks
systems,
service
delivery,
workforce,
information
(analogous
medicines),
financing,
leadership
governance,
as
basis.
Given
dearth
reliable
comprehensive
data,
Commission's
quantify,
where
possible,
state
globally.
We
tracer
conditions
(diabetes,
hypertension,
HIV,
tuberculosis
overall
population,
plus
hepatitis
B
infection
syphilis
pregnant
women)
show
gap
(ie,
proportion
population
condition
who
remain
undiagnosed)
is,
at
35–62%,
single
largest
pathway
(the
cascade
comprising
screening,
diagnosis,
treatment,
cure
successful
management).
also
examine
availability
level
facility,
geography,
socioeconomic
group.
most
severe
primary
which
only
about
19%
populations
low-income
lower-middle-income
countries
have
simplest
tests
(other
than
those
HIV
malaria).
Even
hospitals,
figure
rises
60–70%.
DI
essentially
absent
outside
hospitals.
People
poor,
marginalised,
young,
less
educated
least
Key
messages147%
little
no
diagnostics.2Diagnostics
fundamental
quality
care.
notion
under-recognised,
leading
underfunding
inadequate
resources
levels.3The
so-called
last
mile
particularly
affects
rural,
marginalised
communities
globally;
appropriate
equity
social
justice.4The
emphasised
role
without
diagnostics,
delivery
universal
resistance
mitigation,
preparedness
cannot
be
achieved.5Innovations
years
areas
technology,
workforce)
reduce
gap,
improve
access,
democratise
empower
patients.6As
example
impact,
1·1
million
premature
deaths
middle-income
could
avoided
annually
reducing
conditions:
diabetes,
women.7The
economic
case
investment
strong.
median
benefit–cost
exceeds
one
five
countries,
four
range
1·4:1
24:1.Given
depth
breadth
sustained
quality,
affordable
multi-decade
prioritisation,
commitment,
investment.
Incorporating
into
coverage
packages
begin
process.
147%
24:1.
Our
conclusion
just
under
half
(47%)
world's
estimate
from
35–62%
10%
would
annual
number
(LMICs)
(2·5%
total
LMICs),
disability-adjusted
life-year
(DALY)
losses
38·5
(1·8%
conditions).
policy
environment
conclude
cause
prioritisation
explicitly
mentioned
proposals
largely
missing
national
strategic
plans
health,
focus
National
Action
Plans
Health
Security
limited
primarily
epidemic
infectious
diseases.
corruption
problem
any
system,
susceptible
they
acquisition
expensive
equipment
supplies.
scarce
operational
level,
necessary
physical
clearly
deficient
facilities,
resulting
weak
services
quality.
Similarly,
support
capabilities,
management
procurement
technical
supply
chains,
widely
insufficient.
Regarding
shortfall
around
840
000
(using
UK
benchmark),
noting
education
training
enough
maintain
levels.
Quality
safety
mechanisms
standards
LMICs.
For
2019
study
suggested
India
1151
accredited
medical
laboratories,
whereas
USA,
quarter
India's
260
laboratories.
Because
explore
how
framework
Shiffman
Smith
achieve
With
fresh
people's
minds
pandemic,
EDL
(a
useful
tool
way
forward),
might
opportunity
progress.
offers
associated
developed
evidence-based
template
basic
core
integrated
tiered
networks,
designed
meet
needs
predicted
top
20
burden
disease
2030
2040
GBD-20
EDL).
enabler
putative
discuss
technological
innovation
propose
via
changes
policy,
finance,
infrastructure,
proposed
summarised
following
paragraphs
relevant
recommendation.
outlines
investing
provide
analysis
aforementioned
tests.
costs
relatively
simple
calculate,
measuring
benefits
difficult
context-specific,
varying
several
factors,
country
income,
prevalence,
more
effective
treatment.
work
done
area,
making
assumptions,
LMICs
one,
strong
There
means
technology)
multiplicity
challenges
improving
As
solutions,
10
recommendations.
each
recommendation
important
its
own
right,
highly
interdependent.
If
implemented
group,
recommendations
make
substantial
difference.
relative
absence
it
unsurprising
countries.
Therefore,
recommend
develop
strategy
do
so
evidenced-based
network
(this
based
our
template)
model
(recommendation
1).
allocated
different
system
tiers:
point-of-care
investigations
analysers
x-ray
first-level
sophisticated
MRI,
CT,
flow
cytometers,
nucleic
acid
analysers,
microbial
identification)
higher
facilities.
Implementation
serve
drive
staff,
equipment,
finance)
system.
existing
facilities
adapt
their
context.
However,
whatever
adopted
evidence-based.
biggest
provision
entry
point
cascade,
that,
priority,
(point-of-care
ultrasound)
made
health-care
centres
2).
workforce
expansion
services.
Expansion
approaches
alone
New
needed
ensure
contemporary
skills,
including
competency-based
education,
expanded
continuing
professional
development,
telehealth
remote
services,
greater
task
shifting
sharing.
expand
size
3).
Without
systems
questionable
value,
potentially
causing
harm
wasting
resources.
regulatory
addresses
essential.
Device
regulation
simplified
regional
harmonisation
programmes
prequalification.
implementation
accreditation
competencies.
develops
governance
4).
adequate
always
supporting
improvement
outlined
Commission.
These
include
efficient
through
management,
pooled
standardisation,
fostering
manufacturing
capacity,
development
public–private
partnerships
manufacturers.
additional
financing
generally
essential,
majority
domestic
public.
Higher
taxes
tobacco
(so-called
sin
taxes)
possibility.
Other
sources
instruments,
Social
Impact
Bonds
Development
Bonds,
rarely
used
borrowing
multilateral
banks.
finance
sustainable
5).
Complementing
improved
international
action
increase
affordability
generally.
Supporting
production
(market
shaping)
affordability.
6).
reason
why
apposite
time
transformative
identify
broad
relating
offer
greatest
potential—namely,
digitalisation,
democratisation
By
enabling
hospital
self-testing
self-sampling),
patient,
patients
marginalised.
To
equity,
privacy,
alignment
briefly
review
general
principles
implementation.
designing
technologies
with,
for,
user,
generating
record
monitoring
indicators,
standards-based
approach
interoperability
conflict
confusion.
depend
communications,
well
effect,
main
continued
innovation,
especially
7).
particular
challenge
third
living
fragile
situations.
complex,
challenging
very
actors
involved.
Within
some
challenges,
coordination
civilian
security
sector
needed,
humanitarian
involved
define
8).
Considering
probably
barrier
resourcing
advocacy
drive,
combining
efforts
levels
activities
diverse
stakeholders.
coordinated
programme
levels,
adopting
World
Assembly
resolution
9).
Finally,
effort
transforming
focused,
persistent,
multi-year,
sustainable,
creation
Alliance
agencies
promote
10).
build
next
steps
should
initiation
programmes,
advocate,
adoption
integral
programme.
Continued
research
fill
gaps;
must
turning
point.
over
transform
world
close
great
does.
Gut,
Journal Year:
2020,
Volume and Issue:
70(3), P. 544 - 554
Published: July 20, 2020
Objective
Complex
phenotypes
captured
on
histological
slides
represent
the
biological
processes
at
play
in
individual
cancers,
but
link
to
underlying
molecular
classification
has
not
been
clarified
or
systematised.
In
colorectal
cancer
(CRC),
grading
is
a
poor
predictor
of
disease
progression,
and
consensus
subtypes
(CMSs)
cannot
be
distinguished
without
gene
expression
profiling.
We
hypothesise
that
image
analysis
cost-effective
tool
associate
complex
features
tissue
organisation
with
outcome
data
resolve
unclassifiable
heterogeneous
cases.
this
study,
we
present
an
image-based
approach
predict
CRC
CMS
from
standard
H&E
sections
using
deep
learning.
Design
Training
evaluation
neural
network
were
performed
total
n=1206
comprehensive
multi-omic
three
independent
datasets
(training
FOCUS
trial,
n=278
patients;
test
rectal
biopsies,
GRAMPIAN
cohort,
n=144
The
Cancer
Genome
Atlas
(TCGA),
n=430
patients).
Ground
truth
calls
ascertained
by
matching
random
forest
single
sample
predictions
classifier.
Results
Image-based
(imCMS)
accurately
classified
unseen
TCGA
(n=431
slides,
AUC)=0.84)
biopsies
(n=265
AUC=0.85).
imCMS
spatially
resolved
intratumoural
heterogeneity
provided
secondary
correlating
bioinformatic
prediction
data.
samples
previously
RNA
profiling,
reproduced
expected
correlations
genomic
epigenetic
alterations
showed
similar
prognostic
associations
as
transcriptomic
CMS.
Conclusion
This
study
shows
classifiers
can
made
images,
opening
door
simple,
cheap
reliable
stratification
within
routine
workflows.
Journal of Personalized Medicine,
Journal Year:
2023,
Volume and Issue:
13(8), P. 1214 - 1214
Published: July 31, 2023
Artificial
Intelligence
(AI)
has
emerged
as
a
transformative
technology
with
immense
potential
in
the
field
of
medicine.
By
leveraging
machine
learning
and
deep
learning,
AI
can
assist
diagnosis,
treatment
selection,
patient
monitoring,
enabling
more
accurate
efficient
healthcare
delivery.
The
widespread
implementation
role
to
revolutionize
patients'
outcomes
transform
way
is
practiced,
leading
improved
accessibility,
affordability,
quality
care.
This
article
explores
diverse
applications
reviews
current
state
adoption
healthcare.
It
concludes
by
emphasizing
need
for
collaboration
between
physicians
experts
harness
full
AI.
Archives of Pathology & Laboratory Medicine,
Journal Year:
2019,
Volume and Issue:
144(2), P. 221 - 228
Published: July 11, 2019
Context.—
Complete
digital
pathology
and
whole
slide
imaging
for
routine
histopathology
diagnosis
is
currently
in
use
few
laboratories
worldwide.
Granada
University
Hospitals,
Spain,
which
comprises
4
hospitals,
adopted
full
primary
2016.
Objective.—
To
describe
the
methodology
resulting
experience
at
Hospitals
transitioning
to
diagnosis.
Design.—
All
glass
slides
generated
were
digitized
×40
using
Philips
IntelliSite
Pathology
Solution,
includes
an
ultrafast
scanner
image
management
system.
hematoxylin-eosin–stained
preparations
immunohistochemistry
histochemistry
digitized.
The
existing
sample-tracking
software
system
integrated
allow
data
interchange
through
Health
Level
7
protocol.
Results.—
Circa
160
000
specimens
have
been
signed
out
This
more
than
800
slides.
scanning
error
rate
during
implementation
phase
was
below
1.5%,
subsequent
workflow
optimization
rendered
this
negligible.
Since
implementation,
pathologists
21%
cases
per
year
on
average.
Conclusions.—
Digital
adequate
medium
Successful
digitization
relies
sample
tracking
integration
of
information
technology
infrastructure.
Rapid
reliable
equivalent
key
transition
a
fully
workflow.
resulted
efficiency
gains
preanalytical
analytical
phases,
created
basis
computational
pathology:
computer-assisted
tools
aid
Virchows Archiv,
Journal Year:
2018,
Volume and Issue:
474(4), P. 511 - 522
Published: Nov. 23, 2018
Clinical
success
of
immunotherapy
is
driving
the
need
for
new
prognostic
and
predictive
assays
to
inform
patient
selection
stratification.
This
requirement
can
be
met
by
a
combination
computational
pathology
artificial
intelligence.
Here,
we
critically
assess
approaches
supporting
development
standardized
methodology
in
assessment
immune-oncology
biomarkers,
such
as
PD-L1
immune
cell
infiltrates.
We
examine
immunoprofiling
through
spatial
analysis
tumor-immune
interactions
multiplexing
technologies
predictor
response
cancer
treatment.
Further,
discuss
how
integrated
bioinformatics
enable
amalgamation
complex
morphological
phenotypes
with
multiomics
datasets
that
drive
precision
medicine.
provide
an
outline
machine
learning
(ML)
intelligence
tools
illustrate
fields
application
immune-oncology,
pattern-recognition
large
deep
survival
analysis.
Synergies
surgical
analyses
are
expected
improve
stratification
immuno-oncology.
propose
future
clinical
demands
will
best
(1)
dedicated
research
at
interface
bioinformatics,
supported
professional
societies,
(2)
integration
data
sciences
digital
image
education
pathologists.
Pathology - Research and Practice,
Journal Year:
2020,
Volume and Issue:
216(9), P. 153040 - 153040
Published: June 20, 2020
Information,
archives,
and
intelligent
artificial
systems
are
part
of
everyday
life
in
modern
medicine.
They
already
support
medical
staff
by
mapping
their
workflows
with
shared
availability
cases'
referral
information,
as
needed
for
example,
the
pathologist,
this
will
be
increased
future
even
more.
In
radiology,
established
standards
define
information
models,
data
transmission
mechanisms,
workflows.
Other
disciplines,
such
pathology,
cardiology,
radiation
therapy,
now
further
demands
addition
to
these
standards.
Pathology
may
have
highest
technical
on
systems,
very
complex
workflows,
digitization
slides
generating
enormous
amounts
up
Gigabytes
per
biopsy.
This
requires
generated
biopsy,
gigabyte
range.
Digital
pathology
allows
a
change
from
classical
histopathological
diagnosis
microscopes
glass
virtual
microscopy
computer,
multiple
tools
using
intelligence
machine
learning
pathologists
work.
Journal of Clinical Pathology,
Journal Year:
2020,
Volume and Issue:
74(7), P. 443 - 447
Published: July 3, 2020
The
measures
to
control
the
COVID-19
outbreak
will
likely
remain
a
feature
of
our
working
lives
until
suitable
vaccine
or
treatment
is
found.
pandemic
has
had
substantial
impact
on
clinical
services,
including
cancer
pathways.
Pathologists
are
remotely
in
many
circumstances
protect
themselves,
colleagues,
family
members
and
delivery
services.
effects
research
trials
have
also
been
significant
with
changes
protocols,
suspensions
studies
redeployment
resources
COVID-19.
In
this
article,
we
explore
specific
academic
pathology
how
digital
artificial
intelligence
can
play
key
role
safeguarding
services
pathology-based
current
climate
future.